New Program for Alzheimer’s Patients, Caregivers Offered by George Washington University

New Program for Alzheimer’s Patients, Caregivers Offered by George Washington University
Muses Labs has partnered with the George Washington Center for Integrative Medicine (GWCIM) to offer Alzheimer’s disease (AD) patients in the Washington, D.C. area the MEND Protocol (Metabolic Enhancement for Neuro-Degeneration), a comprehensive adherence program supporting patients and their caregivers that helps to improve patient outcomes. The MEND Protocol is a data-driven, technology-enabling, personalized methodology designed to accurately identify and treat a series of drivers of age-related cognitive declines. The program is designed to help patients who are at the threshold of age-related cognitive decline, those with a family history of dementia or patients with mild Alzheimer's. The new method reflects a new approach to address cognitive degeneration-related complex issues and has the potential to improve memory and cognitive function for pre- and early-symptomatic patients. This is how the MEND Protocol works:
  1. Collecting medical data: Doctors, together with other healthcare partners, will evaluate a patient's cognitive function and collect information through genetic testing, lab work, lifestyle, medical history and current medications.
  2. Pinpointing the causes of cognitive decline: There are about 50 known causes of cognitive decline; the active causes vary from person to person. The MEND Protocol studies the information a patient provides to identify the unique combination of their own underlying causes of cognitive decline.
  3. Creating a personalized treatment plan: <
    Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *